Beijing, China

Fugui He

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Amsinomed Medical Co., Ltd. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fugui He. Retrieved from https://idiyas.com/inventor/fugui-he-yaltlil4

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fugui He: Innovator in Biomedical Engineering

Introduction

Fugui He is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biomedical engineering, particularly in the development of advanced vascular stents. With a total of 2 patents, his work focuses on improving the efficacy and safety of stent technology.

Latest Patents

Fugui He's latest patents include a cobalt-chromium alloy stent and a drug-eluting stent. The cobalt-chromium alloy stent comprises several main body units, each made up of supporting rings connected by flexible ribs. The adjacent main body units are linked by connecting ribs. The drug-eluting stent incorporates a drug coating containing arsenic trioxide and tacrolimus. This innovative design effectively inhibits the inflammatory response of vascular endothelial cells and reduces the proliferation of vascular smooth muscle cells, thereby lowering the vascular restenosis rate.

Another notable patent is the degradable biomedical magnesium alloy drug-eluting vascular stent and its preparation method. This stent is composed of a magnesium alloy with specific percentages of Gd, Y, Li, Zn, and Zr. The design ensures good radial support strength and strain dispersion capability. After applying a protective coating, the corrosion resistance of the magnesium alloy stent is significantly enhanced. The stent utilizes an arsenic trioxide/rapamycin and tacrolimus composite drug sustained-release system, which adapts well to the vascular damage repair process. Implantation results in large animals demonstrate the stent's effectiveness in anti-restenosis treatment.

Career Highlights

Fugui He has worked with notable companies in the medical field, including Amsinomed Medical Co., Ltd and Xinxin Medical Technology (Shanghai) Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative medical devices.

Collaborations

Fugui He has collaborated with talented individuals such as Xin Shen and Dongyun Hao. Their combined efforts have led to advancements in the field of biomedical engineering.

Conclusion

Fugui He is a distinguished inventor whose work in vascular stents has the potential to significantly improve patient outcomes. His innovative patents reflect his commitment to advancing medical technology and enhancing the effectiveness of treatments for vascular conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…